Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Neuroendocrine differentiation and an aggressive phenotype is an important feature of castration-resistant prostate cancer (CRPC). Current biomarkers are unable to detect these advanced, treatment refractory variants.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Modlin I
Authors: Modlin I, Kidd M, Rahbar K, Malczewska A, Rajwa P,
Keywords: Biomarker, NETest, PSA, prostate cancer, neuroendocrine phenotype, castration-resistance, neuroendocrine,
Introduction: The absence of an accurate blood biomarker to predict and monitor PRRT is a key unmet need.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Bodei L
Authors: Bodei L, Kidd M, Singh A, van der Zwan W, Severi S,
Keywords: biomarker, PRRT, prediction, NETest, PPQ, CgA, personalized medicine,
Introduction: Neuroendocrine neoplasms of the appendix (ANEN) are one of the most commonly identified gastroentropancreatic tumours (GEP). The aim of this retrospective study was to review the value of Somatostatin Receptor Scintigraphy (SRS) in staging and imaging follow-up of patients with confirmed ANEN, NENG1 and NENG2 in single institution.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Konsek S, Kolasińska-Ćwikła A, Lewczuk-Myślińska A, Kidd M, Buscombe J,
Keywords: appendiceal neuroendocrine neoplasm, ANEN, somatostatin receptor scintigraphy, SRS, NETest,
Introduction: There is currently no effective blood biomarker for lung neuroendocrine neoplasia diagnosis and management.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Modlin I
Authors: Modlin I, Kidd M, Lewczuk-Myślińska A, Chung K, Ćwikła J,
Keywords: bronchopulmonary, lung, biomarker, PCR, diagnostics, progression,
#2216 Predicting Response to PRRT: Development and Validation of a Blood-Based Predictive Biomarker
Introduction: We have developed a blood-based tool (gene expression analysis and tumor grade) for predicting PRRT efficacy.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Bodei L
Authors: Bodei L, Kidd M, van der Zwan W, Singh A, Severi S,
Keywords: Biomarker, carcinoid, PRRT, prediction, therapy, efficacy, stratification,